Cancer costs and financial risk in health care purchasing/commissioning

What is it about?

A diagnosis of cancer triggers a cascade of costs. Cost data for English Primary Care Organisations was analysed over time to determine which cancer costs were most volatile, and hence contributed most to financial risk. Date of reported diagnosis for a huge range of cancers (M/F) in the USA was likewise analysed and a select group of common cancers show strong evidence for long term cyclic behavior.

Featured Image

Why is it important?

Cyclic behavior of cancer costs and the ratio of male to female cancer costs in the USA has been documented elsewhere. A fundamental behavior is shared between the US and the UK.

Perspectives